Opus Genetics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Opus Genetics, Inc. has filed 1,033 SEC EDGAR filings since 29 Apr 2003

SEC filing history

Showing 626-650 of 839 matching filings.

Per page
25
Current page
26
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 9-12-2016

Filing date
12 Sep 2016
Reporting date
12 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2016

Filing date
05 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 7-6-2016

Filing date
11 Jul 2016
Reporting date
06 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jul 2016
Reporting date
06 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
08 Jul 2016
Reporting date
06 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 6-9-2016

Filing date
10 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2016

Filing date
06 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
DEF 14A File 001-34079

REXAHN PHARMACEUTICALS, INC. DEF 14A 6-9-2016

Filing date
18 Apr 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Mar 2016
Reporting date
18 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34079

REXAHN PHARMACEUTICALS, INC 10-K 12-31-2015

Filing date
14 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 3-2-2016

Filing date
02 Mar 2016
Reporting date
02 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-196255

REXAHN PHARMACEUTICALS, INC 424B5 2-26-2016

Filing date
01 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79996

SABBY 13G RNN 2.29.16

Filing date
29 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 2-26-2016

Filing date
26 Feb 2016
Reporting date
26 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Feb 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79996

REXAHN PHARMACEUTICALS, INC.

Filing date
19 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 11-12-2015

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .